IRF Selection
Wednesday, 27 March 2013
New Prostate Cancer Tests May Supplement P.S.A. Testing
Sophisticated new tests might supplement unreliable readings of the protein P.S.A., which often detect cancers that are unlikely to cause harm.
Newer Post
Older Post
Home